Neglected Tropical Diseases in the Post-Genomic Era

Trends in Genetics

Volumn 31, Issue 10, 2015, Pages 539-555

  Buscaglia, Carlos A ^a   Kissinger, Jessica C ^b   Agüero, Fernán ^a  

^a INSTITUTO DE INVESTIGACIONES BIOTECNOLÓGICAS   (Argentina)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; DEVELOPED COUNTRY; DEVELOPING COUNTRY; GENE EXPRESSION; GENOMICS; HUMAN; LOWEST INCOME GROUP; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PARASITOSIS; PRIORITY JOURNAL; REVIEW; TROPICAL DISEASE; VIRUS INFECTION; GENETICS; HUMAN GENOME; MICROBIOLOGY; NEGLECTED DISEASE; PARASITOLOGY; TROPICAL MEDICINE; VIROLOGY;

DEVELOPING COUNTRIES; GENOME, HUMAN; GENOMICS; HUMANS; NEGLECTED DISEASES; TROPICAL MEDICINE;

EID: 84943381449     PISSN: 01689525     EISSN: 13624555     Source Type: Journal    
DOI: 10.1016/j.tig.2015.06.002     Document Type: Review

References (191)

1. Bhopal A., et al. Strength in numbers? Grouping, fund allocation and coordination amongst the neglected tropical diseases. J. Global Health 2013, 3:020302.
2. Holmes P. Neglected tropical diseases in the post-2015 health agenda. Lancet 2014, 383:1803.
3. Kappagoda S., Ioannidis J.P.A. Prevention and control of neglected tropical diseases: overview of randomized trials, systematic reviews and meta-analyses. Bull. World Health Organ. 2014, 92:356-366C.
4. Eberhard M.L., et al. The peculiar epidemiology of dracunculiasis in Chad. Am. J. Trop. Med. Hyg. 2014, 90:61-70.
5. Ramírez J.D., et al. Molecular epidemiology of human oral Chagas disease outbreaks in Colombia. PLoS Negl. Trop. Dis. 2013, 7:e2041.
6. Singh S., et al. Axenic culture of fastidious and intracellular bacteria. Trends Microbiol. 2013, 21:92-99.
7. McNulty S.N., et al. Inter and intra-specific diversity of parasites that cause lymphatic filariasis. Infect. Genet. Evol. 2013, 14:137-146.
8. Peacock L., et al. Meiosis and haploid gametes in the pathogen Trypanosoma brucei. Curr. Biol. 2014, 24:181-186.
9. Tibayrenc M., Ayala F.J. Reproductive clonality of pathogens: a perspective on pathogenic viruses, bacteria, fungi, and parasitic protozoa. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E3305-E3313.
10. Preidis G.A., Hotez P.J. The newest 'omics' - metagenomics and metabolomics - enter the battle against the neglected tropical diseases. PLoS Negl. Trop. Dis. 2015, 9:e0003382.
11. Wolf Y.I., Koonin E.V. Genome reduction as the dominant mode of evolution. Bioessays 2013, 35:829-837.
12. Keeling P.J., Slamovits C.H. Causes and effects of nuclear genome reduction. Curr. Opin. Genet. Dev. 2005, 15:601-608.
13. El-Sayed N.M., et al. Comparative genomics of trypanosomatid parasitic protozoa. Science 2005, 309:404-409.
14. Fraser C.M., et al. Complete genome sequence of Treponema pallidum, the syphilis spirochete. Science 1998, 281:375-388.
15. Stamm L.V. Global challenge of antibiotic-resistant Treponema pallidum. Antimicrob. Agents Chemother. 2010, 54:583-589.
16. Berriman M., et al. The genome of the blood fluke Schistosoma mansoni. Nature 2009, 460:352-358.
17. Tsai I.J., et al. The genomes of four tapeworm species reveal adaptations to parasitism. Nature 2013, 496:57-63.
18. Zarowiecki M., Berriman M. What helminth genomes have taught us about parasite evolution. Parasitology 2015, 142(Suppl. 1):S85-S97.
19. Sommer R.J., Streit A. Comparative genetics and genomics of nematodes: genome structure, development, and lifestyle. Annu. Rev. Genet. 2011, 45:1-20.
20. Peixoto L., et al. Resource integrative genomic approaches highlight a family of parasite-specific kinases that regulate host responses. Cell Host Microbe 2010, 8:208-218.
21. Guizetti J., Scherf A. Silence, activate, poise and switch! Mechanisms of antigenic variation in Plasmodium falciparum. Cell. Microbiol. 2013, 15:718-726.
22. Buscaglia C.A., et al. Trypanosoma cruzi surface mucins: host-dependent coat diversity. Nat. Rev. Microbiol. 2006, 4:229-236.
23. De Pablos L.M., Osuna A. Multigene families in Trypanosoma cruzi and their role in infectivity. Infect. Immun. 2012, 80:2258-2264.
24. Voigt A., et al. The Chlamydia psittaci genome: a comparative analysis of intracellular pathogens. PLoS ONE 2012, 7:e35097.
25. Agüero F., et al. Genomic-scale prioritization of drug targets: the TDR Targets database. Nat. Rev. Drug Discov. 2008, 7:900-907.
26. Crowther G.J., et al. Identification of attractive drug targets in neglected-disease pathogens using an in silico approach. PLoS Negl. Trop. Dis. 2010, 4:e804.
27. Cioli D., et al. Will new antischistosomal drugs finally emerge?. Trends Parasitol. 2008, 24:379-382.
28. Gaba S., et al. Cheminformatics models for inhibitors of Schistosoma mansoni thioredoxin glutathione reductase. ScientificWorldJournal 2014, 2014:957107.
29. Machado C.R., et al. Nucleotide excision repair in Trypanosoma brucei: specialization of transcription-coupled repair due to multigenic transcription. Mol. Microbiol. 2014, 92:756-776.
30. De Gaudenzi J.G., et al. Gene expression regulation in trypanosomatids. Essays Biochem. 2011, 51:31-46.
31. Keene J.D. RNA regulons: coordination of post-transcriptional events. Nat. Rev. Genet. 2007, 8:533-543.
32. Najafabadi H.S., et al. Global identification of conserved post-transcriptional regulatory programs in trypanosomatids. Nucleic Acids Res. 2013, 41:8591-8600.
33. Scott A.L., et al. Filarial and Wolbachia genomics. Parasite Immunol. 2012, 34:121-129.
34. Landmann F., et al. Anti-filarial activity of antibiotic therapy is due to extensive apoptosis after Wolbachia depletion from filarial nematodes. PLoS Pathog. 2011, 7:e1002351.
35. Desjardins C.A., et al. Genomics of Loa loa, a Wolbachia-free filarial parasite of humans. Nat. Genet. 2013, 45:495-500.
36. McNulty S.N., et al. Endosymbiont DNA in endobacteria-free filarial nematodes indicates ancient horizontal genetic transfer. PLoS ONE 2010, 5:e11029.
37. Heitman J. Evolution of eukaryotic microbial pathogens via covert sexual reproduction. Cell Host Microbe 2010, 8:86-99.
38. Dos Vultos T., et al. Evolution and diversity of clonal bacteria: the paradigm of Mycobacterium tuberculosis. PLoS ONE 2008, 3:e1538.
39. Monot M., et al. On the origin of leprosy. Science 2005, 308:1040-1042.
40. Röltgen K., et al. The genome, evolution and diversity of Mycobacterium ulcerans. Infect. Genet. Evol. 2012, 12:522-529.
41. Sibley L.D., Ajioka J.W. Population structure of Toxoplasma gondii: clonal expansion driven by infrequent recombination and selective sweeps. Annu. Rev. Microbiol. 2008, 62:329-351.
42. Tibayrenc M., Ayala F.J. Cryptosporidium, Giardia, Cryptococcus, Pneumocystis genetic variability: cryptic biological species or clonal near-clades?. PLoS Pathog. 2014, 10:e1003908.
43. Stuart K., et al. Kinetoplastids: related protozoan pathogens, different diseases. J. Clin. Invest. 2008, 118:1301-1310.
44. Peacock L., et al. Intraclonal mating occurs during tsetse transmission of Trypanosoma brucei. Parasit. Vectors 2009, 2:43.
45. Koffi M., et al. Population genetics of Trypanosoma brucei gambiense, the agent of sleeping sickness in Western Africa. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:209-214.
46. Duffy C.W., et al. Population genetics of Trypanosoma brucei rhodesiense: clonality and diversity within and between foci. PLoS Negl. Trop. Dis. 2013, 7:e2526.
47. Capewell P., et al. The TgsGP gene is essential for resistance to human serum in Trypanosoma brucei gambiense. PLoS Pathog. 2013, 9:e1003686.
48. Uzureau P., et al. Mechanism of Trypanosoma brucei gambiense resistance to human serum. Nature 2013, 501:430-434.
49. Goodhead I., et al. Whole-genome sequencing of Trypanosoma brucei reveals introgression between subspecies that is associated with virulence. Mbio 2013, 4:e00197-e213.
50. Gibson W., et al. Genetic recombination between human and animal parasites creates novel strains of human pathogen. PLoS Negl. Trop. Dis. 2015, 9:e0003665.
51. Engman D.M., et al. Trypanosoma cruzi exhibits inter- and intra-strain heterogeneity in molecular karyotype and chromosomal gene location. Mol. Biochem. Parasitol. 1987, 22:115-123.
52. Bastien P., et al. Molecular karyotype analysis in Leishmania. Subcell. Biochem. 1992, 18:131-187.
53. Tibayrenc M., Ayala F.J. The clonal theory of parasitic protozoa: 12 years on. Trends Parasitol. 2002, 18:405-410.
54. Akopyants N.S., et al. Demonstration of genetic exchange during cyclical development of Leishmania in the sand fly vector. Science 2009, 324:265-268.
55. Ravel C., et al. First report of genetic hybrids between two very divergent Leishmania species: Leishmania infantum and Leishmania major. Int. J. Parasitol. 2006, 36:1383-1388.
56. Westenberger S.J., et al. Two hybridization events define the population structure of Trypanosoma cruzi. Genetics 2005, 171:527-543.
57. De Freitas J.M., et al. Ancestral genomes, sex, and the population structure of Trypanosoma cruzi. PLoS Pathog. 2006, 2:e24.
58. Rogers M.B., et al. Genomic confirmation of hybridisation and recent inbreeding in a vector-isolated Leishmania population. PLoS Genet. 2014, 10:e1004092.
59. Gaunt M.W., et al. Mechanism of genetic exchange in American trypanosomes. Nature 2003, 421:936-939.
60. Inbar E., et al. The mating competence of geographically diverse Leishmania major strains in their natural and unnatural sand fly vectors. PLoS Genet. 2013, 9:e1003672.
61. Peacock L., et al. Mating compatibility in the parasitic protist Trypanosoma brucei. Parasit. Vectors 2014, 7:78.
62. Perrin N. What uses are mating types? The 'developmental switch' model. Evolution 2012, 66:947-956.
63. Harris S.R., et al. Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat. Genet. 2012, 44:413-419.
64. Joseph S.J., et al. Population genomics of Chlamydia trachomatis: insights on drift, selection, recombination, and population structure. Mol. Biol. Evol. 2012, 29:3933-3946.
65. Abdelsamed H., et al. Genetic variation in Chlamydia trachomatis and their hosts: impact on disease severity and tissue tropism. Future Microbiol. 2013, 8:1129-1146.
66. Doig K.D., et al. On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics 2012, 13:258.
67. Marion E., et al. Mycobacterial toxin induces analgesia in buruli ulcer by targeting the angiotensin pathways. Cell 2014, 157:1565-1576.
68. Ho E.L., Lukehart S.A. Syphilis: using modern approaches to understand an old disease. J. Clin. Invest. 2011, 121:4584-4592.
69. Gray R.R., et al. Molecular evolution of the tprC, D, I, K, G, and J genes in the pathogenic genus Treponema. Mol. Biol. Evol. 2006, 23:2220-2233.
70. Harper K.N., et al. On the origin of the treponematoses: a phylogenetic approach. PLoS Negl. Trop. Dis. 2008, 2:e148.
71. Knauf S., et al. Treponema infection associated with genital ulceration in wild baboons. Vet. Pathol. 2012, 49:292-303.
72. Cha J.Y., et al. A novel beta-lactamase activity from a penicillin-binding protein of Treponema pallidum and why syphilis is still treatable with penicillin. J. Biol. Chem. 2004, 279:14917-14921.
73. Talbi C., et al. Evolutionary history and dynamics of dog rabies virus in western and central Africa. J. Gen. Virol. 2009, 90:783-791.
74. Parameswaran P., et al. Genome-wide patterns of intrahuman dengue virus diversity reveal associations with viral phylogenetic clade and interhost diversity. J. Virol. 2012, 86:8546-8558.
75. Deitsch K.W., et al. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 2009, 7:493-503.
76. Dos Santos S., et al. The MASP family of Trypanosoma cruzi: changes in gene expression and antigenic profile during the acute phase of experimental infection. PLoS Negl. Trop. Dis. 2012, 6:e1779.
77. Kahn S.J., et al. Trypanosoma cruzi: monoclonal antibodies to the surface glycoprotein superfamily differentiate subsets of the 85-kDa surface glycoproteins and confirm simultaneous expression of variant 85-kDa surface glycoproteins. Exp. Parasitol. 1999, 92:48-56.
78. Stoco P.H., et al. Genome of the avirulent human-infective trypanosome - Trypanosoma rangeli. PLoS Negl. Trop. Dis. 2014, 8:e3176.
79. Campo V., et al. Differential accumulation of mutations localized in particular domains of the mucin genes expressed in the vertebrate host stage of Trypanosoma cruzi. Mol. Biochem. Parasitol. 2004, 133:81-91.
80. Ivens A.C., et al. The genome of the kinetoplastid parasite, Leishmania major. Science 2005, 309:436-442.
81. Peacock C.S., et al. Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat. Genet. 2007, 39:839-847.
82. Downing T., et al. Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res. 2011, 21:2143-2156.
83. Rogers M.B., et al. Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res. 2011, 21:2129-2142.
84. Lachaud L., et al. Constitutive mosaic aneuploidy is a unique genetic feature widespread in the Leishmania genus. Microbes Infect. 2014, 16:61-66.
85. Sterkers Y., et al. FISH analysis reveals aneuploidy and continual generation of chromosomal mosaicism in Leishmania major. Cell. Microbiol. 2011, 13:274-283.
86. McDaniel J.P., Dvorak J.A. Identification, isolation, and characterization of naturally-occurring Trypanosoma cruzi variants. Mol. Biochem. Parasitol. 1993, 57:213-222.
87. Lima F.M., et al. Interclonal variations in the molecular karyotype of Trypanosoma cruzi: chromosome rearrangements in a single cell-derived clone of the G strain. PLoS ONE 2013, 8:e63738.
88. Urban I., et al. Molecular diversity of the Trypanosoma cruzi TcSMUG family of mucin genes and proteins. Biochem. J. 2011, 438:303-313.
89. Burgos J.M., et al. Differential distribution of genes encoding the virulence factor trans-sialidase along Trypanosoma cruzi Discrete typing units. PLoS ONE 2013, 8:e58967.
90. Minning T.A., et al. Widespread, focal copy number variations (CNV) and whole chromosome aneuploidies in Trypanosoma cruzi strains revealed by array comparative genomic hybridization. BMC Genomics 2011, 12:139.
91. Torres E.M., et al. Aneuploidy: cells losing their balance. Genetics 2008, 179:737-746.
92. Kwon-Chung K.J., Chang Y.C. Aneuploidy and drug resistance in pathogenic fungi. PLoS Pathog. 2012, 8:e1003022.
93. Spakulová M., et al. Cytogenetics and chromosomes of tapeworms (Platyhelminthes, Cestoda). Adv. Parasitol. 2011, 74:177-230.
94. Hirt R.P., et al. Lateral gene transfers and the origins of the eukaryote proteome: a view from microbial parasites. Curr. Opin. Microbiol. 2014, 23C:155-162.
95. Gupta R.S., Griffiths E. Chlamydiae-specific proteins and indels: novel tools for studies. Trends Microbiol. 2006, 14:527-535.
96. Silva D.C.F., et al. Examining marginal sequence similarities between bacterial type III secretion system components and Trypanosoma cruzi surface proteins: horizontal gene transfer or convergent evolution?. Front. Genet. 2013, 4:143.
97. Beverley S.M. Protozomics: trypanosomatid parasite genetics comes of age. Nat. Rev. Genet. 2003, 4:11-19.
98. Britton C., et al. Ups and downs of RNA interference in parasitic nematodes. Exp. Parasitol. 2012, 132:56-61.
99. Sassetti C.M., et al. Genes required for mycobacterial growth defined by high density mutagenesis. Mol. Microbiol. 2003, 48:77-84.
100. Griffin J.E., et al. High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism. PLoS Pathog. 2011, 7:e1002251.
101. Rengarajan J., et al. Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. U.S.A. 2005, 102:8327-8332.
102. Kolev N.G., et al. RNA interference in protozoan parasites: achievements and challenges. Eukaryot. Cell 2011, 10:1156-1163.
103. Alsford S., et al. High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome. Genome Res. 2011, 21:915-924.
104. Glover L., et al. Genome-scale RNAi screens for high-throughput phenotyping in bloodstream-form African trypanosomes. Nat. Protoc. 2015, 10:106-133.
105. Alsford S., et al. Cathepsin-L can resist lysis by human serum in Trypanosoma brucei brucei. PLoS Pathog. 2014, 10:e1004130.
106. Baker N., et al. Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6. Mol. Biochem. Parasitol. 2011, 176:55-57.
107. Alsford S., et al. High-throughput decoding of antitrypanosomal drug efficacy and resistance. Nature 2012, 482:232-236.
108. DeJesus M.A., et al. Bayesian analysis of gene essentiality based on sequencing of transposon insertion libraries. Bioinformatics 2013, 29:695-703.
109. Damasceno J.D., et al. A transposon toolkit for gene transfer and mutagenesis in protozoan parasites. Genetica 2010, 138:301-311.
110. Peng D., et al. CRISPR-Cas9-mediated single-gene and gene family disruption in Trypanosoma cruzi. Mbio 2014, 6:e02097-e2114.
111. Wagner J.C., et al. Efficient CRISPR-Cas9-mediated genome editing in Plasmodium falciparum. Nat. Methods 2014, 11:915-918.
112. Sidik S.M., et al. Efficient genome engineering of Toxoplasma gondii using CRISPR/Cas9. PLoS ONE 2014, 9:e100450.
113. Dubourg G., et al. Culturomics and pyrosequencing evidence of the reduction in gut microbiota diversity in patients with broad-spectrum antibiotics. Int. J. Antimicrob. Agents 2014, 44:117-124.
114. O'Connell C.M., et al. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease. J. Immunol. 2007, 179:4027-4034.
115. Seth-Smith H.M.B., et al. Co-evolution of genomes and plasmids within Chlamydia trachomatis and the emergence in Sweden of a new variant strain. BMC Genomics 2009, 10:239.
116. Unemo M., et al. The Swedish new variant of Chlamydia trachomatis: genome sequence, morphology, cell tropism and phenotypic characterization. Microbiology 2010, 156:1394-1404.
117. Reuter S., et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public health microbiology. JAMA Intern. Med. 2013, 173:1397-1404.
118. Seth-Smith H.M.B., et al. Generating whole bacterial genome sequences of low-abundance species from complex samples with IMS-MDA. Nat. Protoc. 2013, 8:2404-2412.
119. Larsen M.V., et al. Multilocus sequence typing of total-genome-sequenced bacteria. J. Clin. Microbiol. 2012, 50:1355-1361.
120. Tritten L., et al. Detection of circulating parasite-derived microRNAs in filarial infections. PLoS Negl. Trop. Dis. 2014, 8:e2971.
121. Poole C.B., et al. Diversity and expression of microRNAs in the filarial parasite, Brugia malayi. PLoS ONE 2014, 9:e96498.
122. Carmona S.J., et al. Towards high-throughput immunomics for infectious diseases: use of next-generation peptide microarrays for rapid discovery and mapping of antigenic determinants. Mol. Cell. Proteomics 2015, 14:1871-1884.
123. De Marchi C.R., et al. Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas' disease. Clin. Vaccine Immunol. 2011, 18:1850-1855.
124. Risso M.G., et al. Immunological identification of Trypanosoma cruzi lineages in human infection along the endemic area. Am. J. Trop. Med. Hyg. 2011, 84:78-84.
125. Legutki J.B., et al. Scalable high-density peptide arrays for comprehensive health monitoring. Nat. Commun. 2014, 5:4785.
126. Kwiatkowski D.P. How malaria has affected the human genome and what human genetics can teach us about malaria. Am. J. Hum. Genet. 2005, 77:171-192.
127. Natividad A., et al. Susceptibility to sequelae of human ocular chlamydial infection associated with allelic variation in IL10 cis-regulation. Hum. Mol. Genet. 2008, 17:323-329.
128. Thomson R., et al. Evolution of the primate trypanolytic factor APOL1. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E2130-E2139.
129. Pozzoli U., et al. The role of protozoa-driven selection in shaping human genetic variability. Trends Genet. 2010, 26:95-99.
130. Frade A.F., et al. Genetic susceptibility to Chagas disease cardiomyopathy: involvement of several genes of the innate immunity and chemokine-dependent migration pathways. BMC Infect. Dis. 2013, 13:587.
131. Williams-Blangero S., et al. Host genetics and population structure effects on parasitic disease. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2012, 367:887-894.
132. Quinnell R.J. Genetics of susceptibility to human helminth infection. Int. J. Parasitol. 2003, 33:1219-1231.
133. Nogueira L.G., et al. Functional IL18 polymorphism and susceptibility to chronic Chagas disease. Cytokine 2015, 73:79-83.
134. Skallerup P., et al. Detection of a quantitative trait locus associated with resistance to Ascaris suum infection in pigs. Int. J. Parasitol. 2012, 42:383-3891.
135. McManus C., et al. Genetic factors of sheep affecting gastrointestinal parasite infections in the Distrito Federal, Brazil. Vet. Parasitol. 2009, 166:308-313.
136. Auburn S., et al. Association of the GNAS locus with severe malaria. Hum. Genet. 2008, 124:499-506.
137. Jallow M., et al. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat. Genet. 2009, 41:657-665.
138. Salinas J.L., et al. Metabolomics in the fight against malaria. Mem. Inst. Oswaldo Cruz 2014, 109:589-597.
139. Síma M., et al. Genetic control of resistance to Trypanosoma brucei brucei infection in mice. PLoS Negl. Trop. Dis. 2011, 5:e1173.
140. Sohrabi Y., et al. Mapping the genes for susceptibility and response to Leishmania tropica in mouse. PLoS Negl. Trop. Dis. 2013, 7:e2282.
141. Schamber-Reis B.L.F., et al. UNC93B1 and nucleic acid-sensing Toll-like receptors mediate host resistance to infection with Leishmania major. J. Biol. Chem. 2013, 288:7127-7136.
142. Simpson L., et al. Evolution of RNA editing in trypanosome mitochondria. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:6986-6993.
143. Borst P., Sabatini R. Base J: discovery, biosynthesis, and possible functions. Annu. Rev. Microbiol. 2008, 62:235-251.
144. Stinear T.P., et al. Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res. 2007, 17:192-200.
145. Wattam A.R., et al. PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res. 2014, 42:D581-D591.
146. Franzén O., et al. Shotgun sequencing analysis of Trypanosoma cruzi I Sylvio X10/1 and comparison with T. cruzi VI CL Brener. PLoS Negl. Trop. Dis. 2011, 5:e984.
147. El-Sayed N.M., et al. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 2005, 309:409-415.
148. Aslett M., et al. TriTrypDB: a functional genomic resource for the Trypanosomatidae. Nucleic Acids Res. 2010, 38:D457-D462.
149. Guzman M.G., et al. Dengue: a continuing global threat. Nat. Rev. Microbiol. 2015, 8(Suppl.):S7-S16.
150. Gebhard L.G., et al. Functional RNA elements in the dengue virus genome. Viruses 2011, 3:1739-1756.
151. Pickett B.E., et al. ViPR: an open bioinformatics database and analysis resource for virology research. Nucleic Acids Res. 2012, 40:D593-D598.
152. Zheng H., et al. The genome of the hydatid tapeworm Echinococcus granulosus. Nat. Genet. 2013, 45:1168-1175.
153. Cwiklinski K., et al. The Fasciola hepatica genome: gene duplication and polymorphism reveals adaptation to the host environment and the capacity for rapid evolution. Genome Biol. 2015, 16:71.
154. Berriman M., et al. The genome of the African trypanosome Trypanosoma brucei. Science 2005, 309:416-422.
155. Jackson A.P., et al. The genome sequence of Trypanosoma brucei gambiense, causative agent of chronic human African trypanosomiasis. PLoS Negl. Trop. Dis. 2010, 4:e658.
156. Raymond F., et al. Genome sequencing of the lizard parasite Leishmania tarentolae reveals loss of genes associated to the intracellular stage of human pathogenic species. Nucleic Acids Res. 2012, 40:1131-1147.
157. Real F., et al. The genome sequence of Leishmania (Leishmania) amazonensis: functional annotation and extended analysis of gene models. DNA Res. 2013, 20:567-581.
158. Cole S.T., et al. Massive gene decay in the leprosy bacillus. Nature 2001, 409:1007-1011.
159. Schuenemann V.J., et al. Genome-wide comparison of medieval and modern Mycobacterium leprae. Science 2013, 341:179-183.
160. Ghedin E., et al. Draft genome of the filarial nematode parasite Brugia malayi. Science 2007, 317:1756-1760.
161. Tordo N., et al. Completion of the rabies virus genome sequence determination: highly conserved domains among the L (polymerase) proteins of unsegmented negative-strand RNA viruses. Virology 1988, 165:565-576.
162. Young N.D., et al. Whole-genome sequence of Schistosoma haematobium. Nat. Genet. 2012, 44:221-225.
163. Protasio A.V., et al. A systematically improved high quality genome and transcriptome of the human blood fluke Schistosoma mansoni. PLoS Negl. Trop. Dis. 2012, 6:e1455.
164. Zerlotini A., et al. SchistoDB: an updated genome resource for the three key schistosomes of humans. Nucleic Acids Res. 2013, 41:D728-D731.
165. Martin J., et al. Nematode.net update 2011: addition of data sets and tools featuring next-generation sequencing data. Nucleic Acids Res. 2012, 40:D720-D728.
166. Thomson N.R., et al. Chlamydia trachomatis: genome sequence analysis of lymphogranuloma venereum isolates. Genome Res. 2008, 18:161-171.
167. Seth-Smith H.M.B., et al. Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res. 2013, 23:855-866.
168. Carlton J.M., et al. Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis. Science 2007, 315:207-212.
169. Pětrošová H., et al. Whole genome sequence of Treponema pallidum ssp. pallidum, strain Mexico A, suggests recombination between yaws and syphilis strains. PLoS Negl. Trop. Dis. 2012, 6:e1832.
170. Cox F.E. History of the discovery of the malaria parasites and their vectors. Parasit. Vectors 2010, 3:5.
171. Trager W., Jensen J.B. Human malaria parasites in continuous culture. Science 1976, 193:673-675.
172. Development of recommendations for the protection of short-stay travellers to malaria endemic areas: memorandum from two WHO Meetings. Bull. World Health Organ. 1988, 66:177-196. WHO Malaria Action Programme.
173. Sanderson A., et al. Enzyme typing of Plasmodium falciparum from African and some other Old World countries. Trans. R. Soc. Trop. Med. Hyg. 1981, 75:263-267.
174. Walliker D., et al. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 1987, 236:1661-1666.
175. Wellems T.E., et al. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 1990, 345:253-255.
176. Su X., et al. A genetic map and recombination parameters of the human malaria parasite Plasmodium falciparum. Science 1999, 286:1351-1353.
177. Su X-Z., Wellems T.E. Toward a high-resolution Plasmodium falciparum linkage map: polymorphic markers from hundreds of simple sequence repeats. Genomics 1996, 33:430-444.
178. Wellems T.E., et al. Genome projects, genetic analysis, and the changing landscape of malaria research. Curr. Opin. Microbiol. 1999, 2:415-419.
179. Fidock D.A., et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol. Cell 2000, 6:861-871.
180. Sidhu A.B.S., et al. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 2002, 298:210-213.
181. Djimdé A., et al. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 2001, 344:257-263.
182. Wootton J.C., et al. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 2002, 418:320-323.
183. Volkman S.K., et al. A genome-wide map of diversity in Plasmodium falciparum. Nat. Genet. 2007, 39:113-119.
184. Miotto O., et al. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nat. Genet. 2015, 47:226-234.
185. Roper C., et al. Intercontinental spread of pyrimethamine-resistant malaria. Science 2004, 305:1124.
186. Maïga O., et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J. Infect. Dis. 2007, 196:165-172.
187. Plowe C.V., et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J. Infect. Dis. 1997, 176:1590-1596.
188. Mikolajczak S.A., et al. Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice. Cell Host Microbe 2015, 17:526-535.
189. Chang J. Core services: reward bioinformaticians. Nature 2015, 520:151-152.
190. Savage N. Bioinformatics: big data versus the big C. Nature 2014, 509:S66-S67.
191. Armstrong-James D., et al. A neglected epidemic: fungal infections in HIV/AIDS. Trends Microbiol. 2014, 22:120-127.